Trevi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.About TRVI
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease, and refractory chronic cough.
TRVI Key Statistics
Stock Snapshot
The current Trevi Therapeutics(TRVI) stock price is $14.44, with a market capitalization of 2.13B. The stock trades at a price-to-earnings (P/E) ratio of -37.68.
On 2026-11-11, Trevi Therapeutics(TRVI) stock traded between a low of $13.64 and a high of $15.25. Shares are currently priced at $14.44, which is +5.9% above the low and -5.3% below the high.
Trevi Therapeutics(TRVI) shares are trading with a volume of 2.32M, against a daily average of 1.61M.
In the last year, Trevi Therapeutics(TRVI) shares hit a 52-week high of $20.22 and a 52-week low of $9.82.
In the last year, Trevi Therapeutics(TRVI) shares hit a 52-week high of $20.22 and a 52-week low of $9.82.
TRVI News
Trevi Therapeutics (TRVI) just released updated figures, reporting a third quarter net loss of US$21.45 million and a nine month loss of US$52.44 million, givin...
...
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.